Physician profile
Tarun Rustagi
NPI 1801045513
$32,210.77
in general payments reported to CMS, 2019-2025
14 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,422 · 2020: $7,623 · 2021: $1,377 · 2022: $3,357 · 2023: $17K · 2024: $581 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Consulting Fee: $3,750 · Food and Beverage: $1,376 · Travel and Lodging: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,075.00 |
| Consulting Fee | $3,750.00 |
| Food and Beverage | $1,375.57 |
| Travel and Lodging | $231.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31,079.99 | 2019-2025 | Acquire, Exalt Model D, General - Biliary Devices |
| Cook Medical LLC | $358.10 | 2019-2023 | Hemospray |
| Abbvie INC. | $209.67 | 2019-2024 | |
| Steris Corporation | $93.25 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.04 | 2019-2024 | Xifaxan |
| Endogastric Solutions, INC | $78.33 | 2022 | |
| Merit Medical Systems INC | $64.10 | 2021-2022 | |
| Olympus America INC. | $55.25 | 2019 | |
| Lumendi LLC | $51.61 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $35.05 | 2023 | Lockado |
| Ucb, INC. | $34.20 | 2019 | |
| Intercept Pharmaceuticals, INC. | $26.33 | 2019 | |
| Celgene Corporation | $18.52 | 2019 | |
| Exelixis INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarun Rustagi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.